FDA Adverse Event Malfunction Summary report: N

ELECSYS DHEA-S

MDR report key: 19342442 · Received May 17, 2024

Report

Report Number
1823260-2024-01487
Event Type
Malfunction
Date Received
May 17, 2024
Date of Event
April 26, 2024
Report Date
June 6, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JKC
UDI-DI
04015630940387
PMA / PMN Number
K003174
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE SAMPLE WAS SUBMITTED FOR INVESTIGATION. UPON FURTHER INVESTIGATION OF THE PATIENT SAMPLE, AN INTERFERENCE AGAINST THE STREPTAVIDIN COMPONENT OF THE REAGENT WAS CONFIRMED. PRODUCT LABELING STATES: "IN RARE CASES, INTERFERENCE DUE TO EXTREMELY HIGH TITERS OF ANTIBODIES TO ANALYTE-SPECIFIC ANTIBODIES, STREPTAVIDIN OR RUTHENIUM CAN OCCUR. THESE EFFECTS ARE MINIMIZED BY SUITABLE TEST DESIGN". THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Additional Manufacturer Narrative · 0

THE E402 ANALYZER SERIAL NUMBER IS (B)(6). THE SAMPLE WAS REQUESTED FOR INVESTIGATION.

Description of Event or Problem · 0

THE INITIAL REPORTER COMPLAINED OF DISCREPANT HIGH RESULTS FOR 1 PATIENT SAMPLE TESTED FOR ELECSYS DHEA-S (DHEA-S) ON A COBAS E 402 ANALYTICAL UNIT. THE INITIAL RESULT WAS > 10.000 UG/DL. THE SAMPLE WAS REPEATED WITH 1:3 DILUTION AND THE RESULT WAS 4.92 UG/DL. THE SAMPLE WAS REPEATED WITH NO DILUTION AND THE RESULT WAS > 10.000 UG/DL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
920672 ELECSYS DHEA-S DEHYDROEPIANDROSTERONE TEST SYSTEM JKC ROCHE DIAGNOSTICS 75160901 04015630940387

Patients

Seq Age Sex Outcome Treatment
1 14 YR Female